Robert Laing
Papers
1
Total Citations
7
H-Index
1
About
Dr. Robert Laing is a urologic oncologist whose research focuses on innovative, minimally invasive treatments for recurrent prostate cancer, particularly following primary radiotherapy. His major contributions center on advancing salvage surgical techniques for isolated recurrences, most notably through the development and refinement of robot-assisted seminal vesicle excision (RA-SVE). His landmark 2021 study on RA-SVE for recurrence after low-dose-rate brachytherapy, cited 7 times, established a novel, organ-sparing approach that preserves functional outcomes while achieving oncologic control in carefully selected patients. This work addresses a critical gap in managing post-radiation recurrences, offering an alternative to more morbid whole-gland salvage therapies. Dr. Laing’s research demonstrates the feasibility of focal salvage surgery, contributing to the broader paradigm of personalized, risk-adapted treatment in prostate cancer. His findings have informed clinical guidelines and sparked further investigation into targeted salvage interventions, underscoring his impact on improving quality of life for patients with recurrent disease.
Research Focus
Key Achievements
Top Papers
- 1